CN108822210B - Chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 protein and application - Google Patents
Chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 protein and application Download PDFInfo
- Publication number
- CN108822210B CN108822210B CN201810691316.8A CN201810691316A CN108822210B CN 108822210 B CN108822210 B CN 108822210B CN 201810691316 A CN201810691316 A CN 201810691316A CN 108822210 B CN108822210 B CN 108822210B
- Authority
- CN
- China
- Prior art keywords
- ppspi24
- kazal
- serine protease
- protein
- protease inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 63
- 239000002435 venom Substances 0.000 title claims abstract description 44
- 210000001048 venom Anatomy 0.000 title claims abstract description 44
- 231100000611 venom Toxicity 0.000 title claims abstract description 44
- 101710102218 Serine protease inhibitor Proteins 0.000 title claims abstract description 43
- 102000004169 proteins and genes Human genes 0.000 title claims description 39
- 241000256808 Pteromalidae Species 0.000 title claims description 19
- 229940122055 Serine protease inhibitor Drugs 0.000 title description 27
- 239000003001 serine protease inhibitor Substances 0.000 title description 27
- 239000002773 nucleotide Substances 0.000 claims abstract description 39
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 39
- 241001454907 Pteromalus puparum Species 0.000 claims abstract description 28
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 25
- 150000001413 amino acids Chemical group 0.000 claims abstract description 15
- 210000000087 hemolymph Anatomy 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 15
- 241000255969 Pieris brassicae Species 0.000 claims abstract description 13
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract description 10
- 230000004913 activation Effects 0.000 claims abstract description 9
- 235000013311 vegetables Nutrition 0.000 claims abstract description 7
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 6
- 230000002265 prevention Effects 0.000 claims abstract description 3
- 239000013612 plasmid Substances 0.000 claims description 24
- 241000589158 Agrobacterium Species 0.000 claims description 12
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 10
- 241000907661 Pieris rapae Species 0.000 claims description 5
- 241000255952 Papilio Species 0.000 claims description 3
- 241000255777 Lepidoptera Species 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 abstract description 13
- 238000012258 culturing Methods 0.000 abstract description 6
- 150000003839 salts Chemical class 0.000 abstract description 4
- 241001672694 Citrus reticulata Species 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 13
- 239000000523 sample Substances 0.000 description 12
- 230000009261 transgenic effect Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 244000128833 Mimulus luteus Species 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 10
- 241000219194 Arabidopsis Species 0.000 description 9
- 241000238631 Hexapoda Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 108010069727 pro-phenoloxidase Proteins 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000013604 expression vector Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- 241001454908 Pteromalus Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000001976 enzyme digestion Methods 0.000 description 6
- 150000007523 nucleic acids Chemical group 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 5
- 241000382353 Pupa Species 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 241001481304 Vespoidea Species 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000009465 prokaryotic expression Effects 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- 101710195006 Venom serine protease inhibitor Proteins 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 101150054900 gus gene Proteins 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 230000003071 parasitic effect Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 101100438273 Arabidopsis thaliana CAN1 gene Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000255908 Manduca sexta Species 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 101710099833 Venom protein Proteins 0.000 description 2
- 241000256856 Vespidae Species 0.000 description 2
- 241000726445 Viroids Species 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 241000256118 Aedes aegypti Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- CYBJZLQSUJEMAS-LFSVMHDDSA-N Ala-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)N)O CYBJZLQSUJEMAS-LFSVMHDDSA-N 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- DPLFNLDACGGBAK-KKUMJFAQSA-N Arg-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N DPLFNLDACGGBAK-KKUMJFAQSA-N 0.000 description 1
- AMIQZQAAYGYKOP-FXQIFTODSA-N Arg-Ser-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O AMIQZQAAYGYKOP-FXQIFTODSA-N 0.000 description 1
- LUVODTFFSXVOAG-ACZMJKKPSA-N Asn-Cys-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)N LUVODTFFSXVOAG-ACZMJKKPSA-N 0.000 description 1
- FODVBOKTYKYRFJ-CIUDSAMLSA-N Asn-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N FODVBOKTYKYRFJ-CIUDSAMLSA-N 0.000 description 1
- ZELQAFZSJOBEQS-ACZMJKKPSA-N Asp-Asn-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZELQAFZSJOBEQS-ACZMJKKPSA-N 0.000 description 1
- BKXPJCBEHWFSTF-ACZMJKKPSA-N Asp-Gln-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O BKXPJCBEHWFSTF-ACZMJKKPSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 206010008428 Chemical poisoning Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- CIMULJZTTOBOPN-WHFBIAKZSA-N Gly-Asn-Asn Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CIMULJZTTOBOPN-WHFBIAKZSA-N 0.000 description 1
- VLIJYPMATZSOLL-YUMQZZPRSA-N Gly-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN VLIJYPMATZSOLL-YUMQZZPRSA-N 0.000 description 1
- 241000255967 Helicoverpa zea Species 0.000 description 1
- XGBVLRJLHUVCNK-DCAQKATOSA-N His-Val-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O XGBVLRJLHUVCNK-DCAQKATOSA-N 0.000 description 1
- DVRDRICMWUSCBN-UKJIMTQDSA-N Ile-Gln-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N DVRDRICMWUSCBN-UKJIMTQDSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- CUXRXAIAVYLVFD-ULQDDVLXSA-N Leu-Arg-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CUXRXAIAVYLVFD-ULQDDVLXSA-N 0.000 description 1
- 229910009891 LiAc Inorganic materials 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- ZACMJPCWVSLCNS-JYJNAYRXSA-N Met-Phe-Met Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(O)=O)CC1=CC=CC=C1 ZACMJPCWVSLCNS-JYJNAYRXSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000500113 Microplitis Species 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- FKKHDBFNOLCYQM-FXQIFTODSA-N Pro-Cys-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O FKKHDBFNOLCYQM-FXQIFTODSA-N 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 241000710961 Semliki Forest virus Species 0.000 description 1
- BNFVPSRLHHPQKS-WHFBIAKZSA-N Ser-Asp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O BNFVPSRLHHPQKS-WHFBIAKZSA-N 0.000 description 1
- LALNXSXEYFUUDD-GUBZILKMSA-N Ser-Glu-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LALNXSXEYFUUDD-GUBZILKMSA-N 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- FPCIBLUVDNXPJO-XPUUQOCRSA-N Val-Cys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O FPCIBLUVDNXPJO-XPUUQOCRSA-N 0.000 description 1
- YLBNZCJFSVJDRJ-KJEVXHAQSA-N Val-Thr-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O YLBNZCJFSVJDRJ-KJEVXHAQSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012681 biocontrol agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000000861 blow drying Methods 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000021523 carboxylation Effects 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000001279 glycosylating effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005745 host immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 108091006086 inhibitor proteins Proteins 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 description 1
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 108700004896 tripeptide FEG Proteins 0.000 description 1
- 239000002578 wasp venom Substances 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Insects & Arthropods (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a pteromalus puparum venom Kazal-type serine protease inhibitor protein PpSPI24, which has the amino acid sequence shown in SEQ ID NO: 2, or a pharmaceutically acceptable salt thereof. The invention also discloses a gene for coding the pteromalus puparum venom Kazal-type serine protease inhibitor protein PpSPI24, which has the nucleotide sequence shown in SEQ ID NO: 1 at positions 70-231. The inhibitor can be used for inhibiting the activation of the cabbage butterfly or the butterfly mandarin orange haemolymph PPO. The invention also discloses a method for improving the prevention of lepidopteran pests by cruciferous vegetables, which comprises the following steps of: 1, and then culturing the transformed cruciferous vegetable cells into plants.
Description
Technical Field
The present invention relates to the fields of molecular biology, genetic engineering and protein engineering. In particular to a Kazal-type serine protease inhibitor protein PpSPI24 expressed in pteromalus puparum venom, a coded nucleic acid sequence and application thereof.
Background
The pests are a serious threat to the safe production of global crops, the yield of the global crops is reduced by about 1/4 every year, and the economic loss is huge. In China, agricultural pests are also important restriction factors which always restrict agricultural yield increase and quality improvement of agricultural products, and statistics show that the national pest and disease occurrence area in 2014 is about 55 hundred million mu/time. The grain loss recovered by preventing and controlling plant diseases and insect pests accounts for 15-20% of the total yield every year, and even so, the grain loss can still reach 300-500 billion jin every year.
Since the introduction of chemical pesticide DDT, pest control has been mainly dependent on chemical pesticides, with the consequences of pest resurgence, pest resistance to drugs, pesticide poisoning, excessive pesticide residue, and serious pollution. People are always exploring and searching for a new effective, safe and low-toxicity pest control method, and with the emergence of transgenic technology, a new idea is provided to solve the pest problem. Since the middle of the 90 s of the 20 th century, the cultivation and application of insect-resistant transgenic crops are successful, and a new machine for effectively controlling pests appears. Statistically, the global transgenic planting area has increased dramatically from about 170 million hectares in 1996 to 1.8 million hectares in 2014 (where the insect-resistant accounts for 43%), with obvious economic and ecological effects also arising.
However, with the continued planting of only a single Bt gene resistant to insect Bt crops, the problem of resistance to the target pests has also become increasingly interesting, and this concern has shown evidence on the cotton bollworm helioera zea of Bt cotton fields. Therefore, on one hand, many scholars search and discover new Bt insect-resistant genes, and on the other hand, protein/peptide genes with insecticidal activity are mined from microorganisms, plants and animals (mainly scorpions and spiders), and novel insect-resistant transgenic plants are cultivated by means of multiple genes or fusion genes and the like, so that the problem of resistance generation of pests is delayed or overcome. Parasitic wasps, as an important biological pest control agent, are well established in the traditional biological control, and play an important role in reducing the use of chemical pesticides and environmental pollution. Parasitic wasps can utilize various parasitic factors (venoms), multi-component DNA viruses (PDVs), viroid particles (VLPs), viroid fibrils (VLFs), Ovarian Proteins (OPs), malformed cells (teratocytes) carried by the parasitic wasps to destroy host immune response, regulate host growth and development, regulate and control host hemolymph nutrient components, disturb host reproductive and endocrine systems and the like so as to ensure that progeny of the parasitic wasps normally develop in or on the blood cavity or body surface of the host. If the parasitic factors of parasitic wasps can be combined with modern biotechnology, the method is expected to be used for developing novel biocontrol agents or transgenic crops, and a new way for biological pest control is developed. For example, the secretory protein gene of the teratocyte of the hamstring scolecularis crocea (Micropliis crocipes) is successfully transferred into the tobacco, and the growth of the tobacco hornworm (Manduca sexta) is obviously slowed down, the harm degree is obviously lower than that of a non-transgenic control, and the tobacco has insect resistance. Rodriguez-Andres and the like transfer Egf1.0 protein in parasitic factor PDV of lateral-destroying swarms (Microplitis demolite) into Semliki Forest virus, can remarkably promote the increment of the virus and enhance the lethal effect of the Rodriguez-Andes aegypti on Aedes aegypti.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a chrysalid pteromalid venom Kazal-type serine protease inhibitor protein PpSPI24 with an immunosuppressive effect (inhibition of hemolymph blackening) on common agricultural pests, and a coding gene and application thereof.
In order to solve the technical problems, the invention provides a pteromalus puparum venom serine protease inhibitor PpSPI24, which has the amino acid sequence shown in SEQ ID NO: 2, or a pharmaceutically acceptable salt thereof.
Remarks explanation: SEQ ID NO: 2 comprises a signal peptide.
MAKSMLIVAFLLVACMMFMHVSAFTDQDGNNCPCATTDDLRYVCGSDGVTYDNESELNCENKCKRSNIQVRFEGKC。
The improvement of the pupa pteromalus venom Kazal-type serine protease inhibitor protein PpSPI24 is as follows: is a protein, a conservative variant thereof, an active fragment thereof or an active derivative thereof.
The invention also provides a gene for coding the pteromalus puparum venom Kazal-type1 serine protease inhibitor protein PpSPI24, which has the nucleotide sequence shown in SEQ ID NO: 1 at positions 70-231; or to SEQ ID NO: 1, the nucleotide sequence from the 70 th to the 231 th nucleotide has at least 70 percent of homology; or the nucleotide sequence of the polypeptide can be matched with the nucleotide sequence shown in SEQ ID NO: 1 from nucleotide positions 70-231.
As an improvement of the gene of the present invention: the sequence of PpSPI24 contains 8-76 continuous nucleotides (namely 8-76 continuous nucleotides in the nucleotide sequence from 70 th to 231 th positions in SEQ ID NO: 1).
The invention also provides the application of the chrysalid pteromalid venom Kazal-type serine protease inhibitor protein PpSPI 24: the protein is used for preparing the pteromalus puparum venom Kazal-type serine protease inhibitor protein, and the inhibitor protein can be used for inhibiting the activation of the pieris rapae hemolymph PPO.
The invention also provides a method for improving the prevention of lepidopteran pests by cruciferous vegetables, which comprises the following steps of: 1, and then culturing the transformed cruciferous vegetable cells into plants.
The chrysalid pteromalid venom Kazal-type serine protease inhibitor protein PpSPI24 and the nucleic acid sequence coded by the same can be applied to the amino acid sequence and the coding sequence of the chrysalid pteromalid venom, and can be developed into insect-resistant crops and biological pesticides with application values and applied to multiple fields of agricultural pest control and the like.
The invention utilizes the genome sequencing of chrysalis to obtain the full-length sequence of venom Kazal-type serine protease inhibitor protein PpSPI24, and obtains the target gene through gene synthesis. After the amino acid sequence of the pteromalus puparum venom Kazal-type serine protease inhibitor protein PpSPI24 is obtained, the pteromalus puparum venom protein PpSPI24 is purified under a non-denaturing condition after prokaryotic expression, and the expressed PpSPI24 can inhibit the activation of a Prophenoloxidase Precursor (PPO) of the pteromalus brassicae pupae of agricultural pests, prevent the prophenoloxidase (PPO) from forming active phenol oxidase, and has the function of inhibiting the humoral immunity of a host.
The invention is realized by the following technical scheme: the DNA molecules isolated in the present invention include: the nucleotide sequence of the protein PpSPI24 with the pteromalus puparum venom Kazal-type serine protease inhibitor is coded, and the nucleotide sequence is similar to the nucleotide sequence shown in SEQ ID NO: 1, the nucleotide sequence from the 70 th to the 231 th nucleotide has at least 70 percent of homology; or the nucleotide sequence can be matched with the nucleotide sequence shown in SEQ ID NO: 1 from nucleotide positions 70-231. Preferably, the sequence encodes a polypeptide having the sequence of SEQ ID NO: 2 in sequence shown in the specification. More preferably, the sequence has the sequence shown in SEQ ID NO: 1 from nucleotide positions 70-231.
The pteromalus puparum venom serine protease inhibitor protein PpSPI24 separated by the invention comprises: has the sequence shown in SEQ ID NO: 2, or a conservative variant thereof, or an active fragment thereof, or an active derivative thereof. Preferably, the protein is a polypeptide having the sequence of SEQ ID NO: 2, or a pharmaceutically acceptable salt thereof.
The DNA molecule of the invention comprises 8-76 consecutive nucleotides in said DNA molecule.
The host cell transformed with the DNA molecule of the invention is a prokaryotic cell.
In the present invention, "isolated", "purified" DNA means that the DNA or fragment has been isolated from the sequences which flank it in the natural state, and that the DNA fragment has been separated from the components which accompany the nucleotides in the natural state, and from the proteins which accompany it in the cell.
In the present invention, the nucleic acid sequence encoded by the pteromalus puparum venom Kazal-type serine protease inhibitor protein PpSPI24 refers to: the nucleotide sequence of the protein with the activity of the pteromalus puparum venom Kazal-type serine protease inhibitor protein PpSPI24 is shown as SEQ ID NO: 1 at positions 70-231 and degenerate sequences thereof. The degenerate sequence is defined as being located in SEQ ID NO: 1 sequence coding box, nucleotide 70-231, having one or more codons substituted by degenerate codons encoding the same amino acid. Due to the degeneracy of the code, the sequence shown in SEQ ID NO: 1. degenerate sequences with nucleotide sequence homologies as low as about 70% at positions 70-231 also encode the amino acid sequence shown in SEQ ID NO: 1.
Also included are compositions that hybridize under moderately stringent conditions, more preferably under highly stringent conditions, to the nucleotide sequence of SEQ ID NO: 1 from the nucleotide sequence at positions 70-231 of the nucleotide. Also included are the sequences substantially identical to SEQ ID NO: 1 from nucleotide 70-231, preferably at least 70%, more preferably at least 80%, still more preferably at least 90%, most preferably at least 95%. Also included are SEQ ID NOs: 1 open variations of the reading frame sequence. These variants include (but are not limited to): deletion, insertion and/or substitution of several (usually 1 to 90, preferably 1 to 60, more preferably 1 to 20, most preferably 1 to 10) nucleotides, and addition of several (usually less than 60, preferably less than 30, more preferably less than 10, most preferably less than 5) nucleotides at the 5 'and/or 3' end.
In the invention, the pupa pteromalus venom Kazal-type serine protease inhibitor PpSPI24 or protein refers to: SEQ ID NO: 2, or a pharmaceutically acceptable salt thereof. The term also includes SEQ ID NO: 2 variant forms of the sequence. These variants include (but are not limited to): deletion, insertion and/or substitution of several (usually 1 to 50, preferably 1 to 30, more preferably 1 to 20, most preferably 1 to 10) amino acids, and addition of one or several (usually up to 20, preferably up to 10, more preferably up to 5) amino acids at the C-terminal and/or N-terminal. For example, in the art, substitutions with amino acids of similar or similar properties will not generally alter the function of the protein. For example, addition of one or several amino acids at the C-terminus and/or N-terminus does not generally alter the function of the protein. The term also includes active fragments and active derivatives of the chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI 24.
The pupa pteromalus venom Kazal-type serine protease inhibitor PpSPI24 conservative variant protein in the invention refers to: and SEQ ID NO: 2, or a protein formed by substituting at most 10, preferably at most 8, and more preferably at most 5 amino acids with similar or similar properties.
The present invention also includes analogs of the pteromalus puparum venom Kazal-type serine protease inhibitor PpSPI24 or proteins that differ from the native Kazal-type serine protease inhibitor either by amino acid sequence differences, by modifications that do not affect the sequence, or by both.
Modified (generally without altering primary structure) forms include: chemically derivatized forms of the protein such as acetylation or carboxylation, in vivo or in vitro. Modifications also include glycosylation, such as those proteins that result from glycosylation modifications during synthesis and processing of the protein or during further processing steps. Such modification may be accomplished by exposing the protein to an enzyme that performs glycosylation, such as mammalian glycosylating or deglycosylating enzymes. Modified forms also include sequences having phosphorylated amino acid residues (e.g., phosphotyrosine, phosphoserine, phosphothreonine). Also included are proteins that have been modified to improve their proteolytic properties or to optimize their solubility properties.
In the present invention, various vectors known in the art, such as commercially available vectors, including plasmids, cosmids, and the like, can be used. When the chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 protein is produced, the chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 coding sequence can be operably connected with an expression regulatory sequence, so that a chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 expression vector is formed.
"operably linked" as used in the present invention refers to the situation where certain parts of a linear DNA sequence are capable of affecting the activity of other parts of the same linear DNA sequence. For example, if the signal peptide DNA is expressed as a precursor and is involved in secretion of the protein, the signal peptide (secretory leader) DNA is operably linked to the protein DNA; a promoter is operably linked to a coding sequence if it controls the transcription of that sequence; a ribosome binding site is operably linked to a coding sequence if it is placed in a position that enables translation. Generally, "operably linked" means adjacent, and for secretory leaders means adjacent in reading frame.
In the present invention the host cell is a prokaryotic cell. A commonly used prokaryotic host cell is referred to as an E.coli cell.
Northern blotting technique or fluorescent quantitative PCR can also be used to analyze the expression of gene product of Kazal-type serine protease inhibitor PpSPI24 in the venom of pteromalus puparum, i.e. to analyze the existence and quantity of RNA transcript of the Kazal-type serine protease inhibitor PpSPI24 in cells.
In addition, the nucleic acid molecules useful as probes in the present invention generally have 8 to 76 consecutive amino acids, preferably 15 to 50 consecutive nucleotides, of the nucleotide coding sequence of the pteromalus puparum venom Kazal-type serine protease inhibitor PpSPI 24. The probe can be used for detecting whether a nucleic acid molecule encoding the pteromalus puparum venom Kazal-type serine protease inhibitor PpSPI24 exists in a sample.
The invention relates to a method for detecting whether a pteromalus puparum venom Kazal-type serine protease inhibitor PpSPI24 nucleotide sequence exists in a sample, which comprises the steps of hybridizing the probe and the sample, and then detecting whether the probe is combined. Preferably, the sample is a product after PCR amplification, wherein the PCR amplification primer corresponds to the nucleotide coding sequence of Kazal-type serine protease inhibitor PpSPI24 of pteromalus puparum venom, and can be positioned at two sides or in the middle of the coding sequence. Primers are typically 15-50 nucleotides in length.
In addition, according to the nucleotide sequence and the amino acid sequence of the chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24, the chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 homologous gene or homologous protein can be screened on the basis of nucleic acid homology or expression protein homology.
The pteromalus puparum venom Kazal-type serine protease inhibitor PpSPI24 nucleotide full-length sequence or the fragment thereof can be obtained by a PCR amplification method, a recombination method or an artificial synthesis method. For PCR amplification, primers can be designed based on the nucleotide sequences disclosed herein, particularly open reading frame sequences, and amplified using a commercially available cDNA library or a cDNA library prepared by conventional methods known to those skilled in the art as a template to obtain the sequence.
Once the sequence of interest has been obtained, it can be obtained in large quantities by recombinant methods. This is usually done by cloning it into a vector, transferring it into a cell, and isolating the relevant sequence from the propagated host cell by conventional methods.
Furthermore, mutations can also be introduced into the protein sequences of the invention by chemical synthesis. By utilizing the chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24, substances or receptors and the like with interaction of the chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 can be screened out through various conventional screening methods.
Other aspects of the invention will be apparent to those skilled in the art in view of the disclosure herein. The invention has obvious inhibition effect in the activation test of important pests of cabbage butterfly hemolymph phenol oxidase of cruciferous vegetables and has obvious inhibition effect on the humoral immunity of cabbage butterfly. The harm of agricultural pests in China is very serious, the negative effect of using chemical pesticides is great, and the chrysalid pteromalid hornet venom Kazal-type serine protease inhibitor PpSPI24 is a new protein with an immunosuppressive effect on the agricultural pests, so that the chrysalid pteromalid hornet venom PpSPI24 has a great application value.
Drawings
The following describes embodiments of the present invention in further detail with reference to the accompanying drawings.
FIG. 1 is a diagram showing the separation and purification of PpSPI24 prokaryotic expression according to the present invention;
note: m is standard protein, lane 1 is colibacillus BL21 uninduced whole protein containing pGEX-4T-2-PpSPI24 plasmid, lane 2 is supernatant after induction of colibacillus BL21 containing pGEX-4T-2-PpSPI24 plasmid, lane 3 is purified chrysalis wasp venom Kazal-type serine protease inhibitor PpSPI24 protein fused with GST tag, and lane 4 is purified GST tag protein.
FIG. 2 is a diagram showing the inhibitory effect of the prokaryotic expression pteromalus puparum venom Kazal-type serine protease inhibitor PpSPI24 gene expression on activation of pieris rapae puparum hemolymph phenol oxidase;
note: M.luteus/GST-PpSPI24 represents 0.5. mu.g of PpSPI24 protein added to M.luteus.
Negative control was TBS buffer added m.luteus; adding 0.5 mu g of tag protein GST of M.luteus; add 0.5 μ g bsa standard protein m.luteus; positive control was TBS buffer without m.luteus.
Detailed Description
The invention is further illustrated below with reference to laboratory specific test data and with reference to specific examples. These examples are intended to illustrate the invention and are not intended to limit the scope of the invention. Experimental procedures without specific conditions noted in the following examples, generally followed by conventional conditions, such as molecular cloning in Sambrook et al: the conditions described in the Laboratory Manual (New York: Cold spring harbor Laboratory Press, 1989), or according to the manufacturer's recommendations.
Example 1:
1. synthesizing chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 gene:
a gene sequence obtained according to the pteromalus puparum genome data-SEQ ID NO: 1, and using SignalP 4.1 to predict the signal peptide on line. The gene sequence is designed and synthesized into single-stranded oligo, and the synthesized oligo is spliced into a complete gene sequence by PCR. Connecting with a vector PGEM-Teasy (Promega), screening by blue white spots, picking out positive clones, and sending the positive clones to Shanghai Boshang company for sequencing inspection.
2. PpSPI24 prokaryotic expression and purification
After the obtained PpSPI24 is full-length, primers for constructing a prokaryotic expression vector are designed by using full-length ORF (signal peptide is removed):
the forward primer pGEX-4T-2-PpSPI 24-SP:
5'-GATCTGGTTCCGCGTGGATCCTTTACCGACCAGGACGGCA-3',
the reverse primer pGEX-4T-2-PpSPI24-AP:
5'-ACGATGCGGCCGCTCGAGTCAGCATTTGCCTTCGAACC-3'。
using a gene fragment plasmid connected to a vector PGEM-T easy (Promega) as a template, and performing PCR amplification by using all gold high fidelity Pfu enzymes, wherein the PpSPI24PCR amplification system is as follows: 3min at 94 ℃, 30sec at 94 ℃, pre-denaturation 30sec at 51 ℃, annealing 30sec at 72 ℃, extension 30sec at 72 ℃, and extension 8min at 72 ℃ after 35 cycles. And after the PCR is finished, carrying out gel cutting and recovery for later use after 1% agarose gel electrophoresis verification. Extracting pGEX-4T-2 plasmid, and carrying out double enzyme digestion on the pGEX-4T-2 plasmid by using BamH I and Xhol I;
the enzyme digestion steps are as follows:
1) enzyme digestion reaction liquid:
2) and (3) after centrifugal mixing, reacting for 2h at 37 ℃, heating for 20min at 37 ℃ to inactivate the enzyme, carrying out gel cutting recovery after enzyme digestion product agarose gel electrophoresis verification, and obtaining the linear pGEX-4T-2 vector. Homologous recombination was performed using the Clonexpress Entry one Cloning Kit. The recombination steps are as follows:
homologous recombination reaction solution:
3) and the mixture is blown up and down for several times by using a pipette, the components are gently mixed and react for 30min at 37 ℃. Immediately after the reaction was completed, the reaction tube was placed in an ice bath and cooled for 5 min. The recombinant plasmid was then transformed into E.coli BL21 E.coli, and added to non-resistant LB liquid medium, cultured at 37 ℃ for 1 hour in an incubator 200r, and then 100. mu.L of the recombinant plasmid was inoculated to LB plates containing 100. mu.g/ml Amp + and cultured overnight. Picking single colony in the next dayAmp + LB liquid medium (Amp + concentration of 100 u g/ml) culture and sequencing detection expression vector success construction. And (3) selecting a single colony containing an expression plasmid (after the single colony plasmid is extracted, the sequence is verified to contain an inserted PpSPI24 sequence in the plasmid, and the plasmid externally shows that the plasmid can grow on an LB solid culture medium containing Amp +), inoculating the single colony containing the inserted PpSPI24 sequence to 5ml of LB solid culture medium (containing 100 mu g/ml Amp +), performing shake culture at 37 ℃ overnight, taking 100 mu l of the bacterial liquid to culture in a fresh 5ml of LB culture medium until the OD is 0.6-0.8 (about 2-3 h), adding 10 mu l of 500mM IPTG to the final concentration of 0.5mM, performing induced expression culture at 37 ℃ for 4-5 h, and collecting cells. Purification of GST-tag-containing fusion PpSPI24 (expressed in E.coli using pGEX-4T-2 expression vector) according to InvitrogenTMThe instructions for the GST Spin Purification Kit were performed. The specific results of expression and purification are shown in FIG. 1.
From fig. 1, it can be seen that: plasmid Escherichia coli BL21 containing pGEX-4T-2-PpSPI24 is expressed in large amount in supernatant after induction, and the purified band is single and about 38 kDa.
3. Determination of PPSPI24 synthesized and expressed on activation inhibition of PPO of Pieris rapae and Papilio citri
Taking the cabbage butterfly pupa hemolymph from one end of the cabbage butterfly pupa hemolymph on ice into a 1.5ml precooling centrifuge tube, immediately placing the centrifuge tube on ice, centrifuging the centrifuge tube for 5 minutes at 3300g at 4 ℃, taking the supernatant into a new precooling 1.5ml centrifuge tube, removing blood cells and using the supernatant for measuring the phenol oxidase background.
The experiments were loaded as follows:
effect on PPO activation:
10 μ l TBS (containing 2 μ l of pupal hemolymph),
10 μ l TBS (2 μ l pupal hemolymph and 0.5 μ g M.luteus),
10 μ l TBS (containing 2 μ l of pupal hemolymph, 0.5 μ g BSA and 0.5 μ g M.luteus),
10 μ l TBS (containing 2 μ l of pupal hemolymph, 0.5 μ g GST and 0.5 μ g M.luteus),
10 μ l TBS (containing 2 μ l of pupal hemolymph, 1 μ l PTU and 0.5 μ g M.luteus),
10ul TBS (containing 2. mu.l of pupal hemolymph, 0.5. mu.g GST-PpSPI expressed by GST fusion and 0.5. mu.g M.luteus);
after 20min at 25 ℃ 200. mu. l L-Dopa (20mM in PBS) was added and the assay was performed once per minute at 470nm absorbance for a total of 30 min. Each sample was repeated a minimum of 3 times. The unit U of phenoloxidase activity means 0.001OD per minute470The value of (c). Data were statistically analyzed using DPS data analysis software (both cheque and von leuton, 2007). The specific results are shown in FIG. 2. The test results prove that: the PpSPI24 protein disclosed by the invention has an inhibitory effect on the PPO activation of Pieris rapae and Papilio citrina.
Example 2
1. Construction of PpSPI24 gene plant binary expression vector
The promoter of Cauliflower mosaic virus CaMV 35S and the NOS terminator on both sides of GUS gene in a plant binary expression vector pBI121 are inserted into PpSPI24 gene to form a complete expression frame. In the experiment, BamH I and Sac I are selected as enzyme cleavage sites to replace GUS gene with PpSPI24, so that expression of PpSPI24 gene in Arabidopsis plants is controlled by using expression frames on two sides of GUS gene.
Designing primers with BamH I and Sac I enzyme cutting sites according to ORF of pteromalus puparum venom serine protease inhibitor, and performing PCR amplification by using pteromalus puparum venom gland cDNA as a template to construct a plant expression vector. The primer sequence is as follows:
PpSPI24-SP:5'-ACGCGTCGACTTTACCGACCAGGACGGCA-3',
PpSPI24-AP:5'-CGCGGATCCTCAGCATTTGCCTTCGAACC-3',
wherein GGATCC is a BamH I cleavage site, and GTCGAC is a Sac I cleavage site. The primers were synthesized by Shanghai Bioengineering Co.
The PCR reaction conditions and system were identical to those of example 1-2 (i.e., the forward primer and the reverse primer were replaced with "PpSPI 24-SP and PpSPI 24-AP", respectively, in the reaction system). And recovering and connecting the PCR product to a pMD18-T vector, transforming escherichia coli Trans T1 competent cells, screening Amp + resistance, and selecting clones to be sent to Shanghai Boshang company for sequencing. Extracting pMD18-PpSPI24 plasmid, carrying out double enzyme digestion on pMD18-PpSPI24 plasmid by using restriction enzymes BamH I and Sac I, cutting glue and recovering small fragments.
The pBI121 plasmid is extracted from overnight cultured bacterial liquid by using a small amount of plasmid extraction kit (Axygen), the pBI121 plasmid is subjected to double enzyme digestion by using restriction enzymes BamHI and SacI, and a large fragment is recovered by gel cutting. The digested pBI121 plasmid and pMD18-PpSPI24 plasmid are connected by T4DNA ligase at 16 ℃ overnight, transformed into escherichia coli Trans T1 competent cells, screened by Kan + resistance, and cloned pBI121-PpSPI24 (the sequence obtained by sequencing is shown as SEQ ID NO: 1) is selected and sent to Shanghai Boshang company for sequencing to verify the correctness of the inserted fragment.
2. Transformation of Agrobacterium with pBI121-PpSPI24
(1) Preparation of Agrobacterium-infected competent cells
a. Streak-culturing the EHA105 strain on a YEP solid culture medium containing 50mg/L Rif, and culturing at 28 ℃ for 24-48 h;
b. selecting monoclonal strain, and shake culturing in 5ml YEP liquid culture medium containing 50mg/L Rif at 28 deg.C for 24-48 h;
c. adding 5ml of the above bacterial solution into 100ml of YEP liquid culture medium containing 50mg/L Rif, and performing shake culture at 28 deg.C for 5-6 h until OD600=0.8。
d. Centrifuging at 5000rpm for 15min at 4 deg.C, and collecting cell precipitate. Adding 50ml of ice-cold sterile water, and suspending the bacterial precipitate;
e. centrifuging at 4 deg.C and 5000rpm for 15min, and repeating with 10ml ice-cold sterile water;
f. adding 10ml of precooled 10% sterile glycerol, and resuspending the precipitate;
g. centrifuging, discarding the supernatant, suspending the precipitate with 2ml of pre-cooled 10% sterile glycerol, packaging and storing at-70 ℃.
(2) Electroporation transformation of Agrobacterium
Taking out the electric shock cup, washing twice with double-distilled water, washing 1-2 times with 75% ethanol (adding 75% ethanol, and shaking twice), placing in a super clean bench, blow-drying (about 10-20 min) from the mouth inwards, covering the blow-dried electric shock cup with a cover, and placing on ice.
From a refrigerator at-70 ℃, an agrobacterium competent cell is taken and placed on ice, when the agrobacterium competent cell is melted into liquid, 2ul of plasmid pBI121-PpSPI24 is added into the competent cell in a super clean bench, the competent cell is flicked by hand, mixed evenly and placed on the ice, and then transferred to a middle gap of an electric shock cup by a pipette. And (4) turning on the electric shock instrument, wiping water outside the electric shock cup by using absorbent paper, putting the electric shock cup into the electric shock cup, and rotating the gear to be tight. The parameters of the electric shock were adjusted (1440HV, 125 Ω, 50uF), and after the electric shock was completed, the cell was placed on ice for 2-3 minutes, then 800ul of LB medium was gently added to the electric shock cup, gently blown down several times with a pipette, and then transferred to an EP tube.
The plate was incubated at 28 ℃ for 48 hours, centrifuged at 4000rpm for 5 minutes, and then plated with Kan + antibiotics. The colonies that grew out were streaked on another plate and then grown for another 24 hours, and then verified by PCR, since Agrobacterium contained a low copy number of plasmid and the number of PCR cycles was set to 40 cycles.
3. Agrobacterium transformation of Arabidopsis thaliana
Transformation of Arabidopsis thaliana was performed by the pollen tube channel method (Clough and Bent 1998). The specific process is as follows:
a single colony of Agrobacterium containing pBI121-PpSPI24 on LB solid medium was picked up, cultured overnight in 4ml LB liquid medium, and expanded at a ratio of 1: 500. OD of bacterial liquid600When the absorption value reaches 0.6-1.0, centrifuging at 4000rpm for 5 minutes and collecting the agrobacterium.
Resuspending Agrobacterium with 5% sucrose solution, and diluting the bacterial solution to OD600About 0.5 to about 0.8, and 0.03% of a surfactant Silvet L-77 is added before use. And selecting arabidopsis thaliana with good growth state, and soaking the flower bud of arabidopsis thaliana in the agrobacterium liquid for 20 seconds. And (4) shading and moisturizing the mixture for 24 hours by using opaque plastic cloth, and then transferring the mixture to a light incubator for continuous culture. The transformation was repeated once a week later.
The transformed Arabidopsis thaliana can be placed under the long-day condition, so that the Arabidopsis thaliana can grow fast to form seeds, and T is collected0And (5) seed generation.
4. Identification of transgenic Arabidopsis thaliana
(1) Kanamycin resistance selection of transgenic plants
a. Taking the harvested T0Seeds of Arabidopsis thaliana (about 100 mg) are placed in a 1.5ml centrifuge tube;
b. Sterilizing with 70% ethanol for 5s, centrifuging for a short time, and removing supernatant;
c. with 10% NaHClO3Disinfecting for 2-3 minutes, centrifuging for a short time, and then discarding the supernatant;
d. adding sterilized distilled water, re-suspending, centrifuging, removing supernatant, and washing for several times;
e. add l ml sterile 0.1% agarose solution to suspend the seeds;
f. spreading Arabidopsis seeds on L/2MS culture medium containing 50mg/L Kan +;
g. vernalizing at a low temperature of 4 ℃ for 2-5 days;
h. transplanting to Arabidopsis thaliana, culturing under normal condition, transplanting Kan + resistant Arabidopsis thaliana seedling to flowerpot with soil, bombax 1, growing in culture room, and collecting T1And (5) seed generation.
(2) PCR identification of Arabidopsis thaliana
Get T1The method for extracting the plant genome DNA from the young leaves of the arabidopsis seedlings comprises the following steps:
a. collection T1Putting 1 young leaf into a centrifugal tube of 1.5ml, injecting liquid nitrogen, and grinding the sample into powder;
b. adding 750 mu l of extraction buffer solution into a centrifuge tube filled with a sample, quickly shaking and uniformly mixing, and placing the centrifuge tube at 65 ℃ for heat preservation for 8-10 min;
c. adding 150 mu l of 5M LiAc, slowly and uniformly mixing, and carrying out ice bath for 15-20 min;
d. centrifuging at 13000rpm for 10min at 4 ℃;
e. transferring 800 μ l of the supernatant into a new centrifuge tube, adding equal volume of isopropanol, reversing, mixing, and precipitating at-20 deg.C for 10 min;
f. centrifuging at 13000rpm for 10min at 4 ℃;
g. washing the precipitate with 75% ethanol, and air drying;
h. the pellet was dissolved in 10. mu.l of TE buffer;
i. diluting the extracted DNA sample by 5-10 times to be used as a PCR reaction template, carrying out PCR reaction according to the method of example 1-1, and identifying the transgenic condition of T1 generation.
70 wild type Arabidopsis plants were transformed by Agrobacterium pollen tube method carrying the recombinant plasmid pBI121-PpSPI24, and several thousand seeds were harvested per plant. Seeds into which foreign genes have been introduced are preliminarily selected by expression of the kanamycin resistance gene, about 3.5 ten thousand seeds are sown, and 72 seeds having kanamycin resistance are finally obtained. The plants are self-pollinated by wrapping the plants with plastic bags to obtain T1Seed generation, and backcross culture to T3And (4) generating homozygotes for subsequent analysis.
5. Insect-resistant analysis of PpSPI24 transgenic Arabidopsis plants
SEQ ID the cabbage caterpillar of about 10 and 2 years old is put into a 15cm culture dish, and soaked cotton balls are placed in the culture dish for moisture preservation. The leaf of 8 leaf stages of adding equivalent lotus throne commentaries on classics PpSPI24 arabidopsis and wild type arabidopsis in every culture dish is given it to eat, and every is handled and is set up 3 and repeat, records each and handles survival and die forget worm number and larva growth situation, in time changes fresh leaf, statistics cabbage worm's death rate. After the cabbage worms are fed for 5 days, the mortality rate of the cabbage worms fed with the transgenic PpSPI24 Arabidopsis leaves is 22 percent and is obviously higher than the mortality rate of a control by 4.2 percent, which indicates that the transgenic PpSPI24 Arabidopsis can inhibit the survival of the cabbage worms and has toxic killing effect on the cabbage worms. The pteromalus puparum venom protein PpSPI24 is expected to have control effect on lepidoptera pests such as cabbage caterpillars and the like when being transferred into other cruciferous vegetables such as cabbage and the like.
Finally, it should also be noted that the above list is only a specific implementation example of the present invention. It is obvious that the invention is not limited to the above embodiment examples, but that many variations are possible. All modifications which can be derived or suggested by a person skilled in the art from the disclosure of the present invention are to be considered within the scope of the invention.
Sequence listing
<110> Zhejiang university
<120> chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 protein and application
<160>2
<170>SIPOSequenceListing 1.0
<210>1
<211>231
<212>DNA
<213> Pteromalus puparum (Pteromalus puprum)
<400>1
atggccaagt ctatgctcat cgttgctttc ctcctcgtcg cctgcatgat gttcatgcac 60
gtgagcgcgt ttaccgacca ggacggcaac aactgtccct gtgccaccac tgacgatctc 120
agatatgttt gcggcagcga cggcgtcacc tacgacaacg agtctgagct caactgcgag 180
aacaagtgca aacgatccaa catccaggtt aggttcgaag gcaaatgctg a 231
<210>2
<211>76
<212>PRT
<213> Pteromalus puparum (Pteromalus puprum)
<400>2
Met Ala Lys Ser Met Leu Ile Val Ala Phe Leu Leu Val Ala Cys Met
1 5 10 15
Met Phe Met His Val Ser Ala Phe Thr Asp Gln Asp Gly Asn Asn Cys
2025 30
Pro Cys Ala Thr Thr Asp Asp Leu Arg Tyr Val Cys Gly Ser Asp Gly
35 40 45
Val Thr Tyr Asp Asn Glu Ser Glu Leu Asn Cys Glu Asn Lys Cys Lys
50 55 60
Arg Ser Asn Ile Gln Val Arg Phe Glu Gly Lys Cys
65 70 75
Claims (4)
1. The pteromalus puparum venom Kazal-type serine protease inhibitor protein PpSPI24 is characterized in that: the amino acid sequence is shown as SEQ ID NO: 2, respectively.
2. The gene encoding the pteromalus puparum venom Kazal-type serine protease inhibitor protein PpSPI24 of claim 1, wherein: the nucleotide sequence is shown as SEQ ID NO: 1 is shown.
3. The use of the chrysalid pteromalid venom Kazal-type serine protease inhibitor protein PpSPI24 as claimed in claim 1, wherein: the PpSPI24 protein is used for inhibiting activation of haemolymph PPO of Pieris rapae or Papilio citri.
4. A method for improving the prevention of lepidopteran pests in cruciferous vegetables, comprising: transforming arabidopsis thaliana with agrobacterium carrying recombinant plasmid pBI121-PpSPI24, wherein the nucleotide sequence of PpSPI24 is shown as SEQ ID NO: 1, the lepidoptera pests are cabbage caterpillars.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810691316.8A CN108822210B (en) | 2018-06-28 | 2018-06-28 | Chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 protein and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810691316.8A CN108822210B (en) | 2018-06-28 | 2018-06-28 | Chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 protein and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108822210A CN108822210A (en) | 2018-11-16 |
CN108822210B true CN108822210B (en) | 2020-04-17 |
Family
ID=64134999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810691316.8A Active CN108822210B (en) | 2018-06-28 | 2018-06-28 | Chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 protein and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108822210B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110590925B (en) * | 2019-09-10 | 2021-05-07 | 浙江大学 | Pteromalus puparum venom protein PpVPG and application thereof |
-
2018
- 2018-06-28 CN CN201810691316.8A patent/CN108822210B/en active Active
Non-Patent Citations (4)
Title |
---|
Identification and characterization of serine protease inhibitors in a parasitic wasp, Pteromalus puparum.;Yang L等;《Scientific Reports》;20171116;第7卷;15755,第1-13页 * |
PREDICTED: Nasonia vitripennis turripeptide Pal9.2-like (LOC100680056), mRNA;登录号:XM_003424928;《GenBank数据库》;20160526;参见序列部分 * |
寄生蜂毒液蛋白组成、功能及进化的研究进展;严智超等;《中国生物防治学报》;20170228;第33卷(第1期);第1-10页 * |
蝶蛹金小蜂毒液蛋白质组与四个毒液蛋白生理功能的分析;王磊;《万方学位论文数据库》;20131008;参见全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN108822210A (en) | 2018-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weng et al. | Transgenic sugarcane plants expressing high levels of modified cry1Ac provide effective control against stem borers in field trials | |
CN108892721B (en) | Chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI20 protein and application | |
WO2015070778A1 (en) | Method for controlling pest | |
JPS6094041A (en) | Insect resistant plant | |
WO2015070780A1 (en) | Method for controlling pests | |
WO2016184396A1 (en) | Application of insecticidal protein | |
WO2015067194A1 (en) | Method for controlling pests | |
WO2016138819A1 (en) | Uses of insecticidal protein | |
WO2016101683A1 (en) | Uses of insecticidal protein | |
WO2015070781A1 (en) | Method for controlling pests | |
WO2016101612A1 (en) | Pest control method | |
CN106832001B (en) | Insecticidal fusion protein, encoding gene and application thereof | |
WO2009018739A1 (en) | Bacillus thuringiensis strain, cry8h genes, proteins, which are all highly toxic to order coleoptera insect pests, and uses thereof | |
CN105440131A (en) | Pteromalus puparumvenom serine protease inhibitor PpSerpin protein and application thereof | |
WO2016184387A1 (en) | Use of pesticidal protein | |
CN106834318A (en) | A kind of insect-resistant fusion gene, encoding proteins and its application | |
CN113621643A (en) | Application of GhTULP34 in regulation and control of plant resistance to abiotic adversity stress and regulation and control method | |
CN108822210B (en) | Chrysalid pteromalid venom Kazal-type serine protease inhibitor PpSPI24 protein and application | |
WO2016184397A1 (en) | Application of insecticidal protein | |
WO2016101684A1 (en) | Uses of insecticidal protein | |
US6280722B1 (en) | Antifungal Bacillus thuringiensis strains | |
CN107106634A (en) | Cry1Ca toxin available for the modification of control insect pest | |
CN102260348B (en) | Pteromalus puparum venom serine protease inhibitor Pp-PI polypeptide and application thereof | |
CN114438118A (en) | Method for efficiently expressing Bt protein Cry56Aa1 in rice and corn to resist spodoptera frugiperda | |
CN111560055B (en) | Application of rice gene OsLAT3 in regulation of absorption and accumulation of diquat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |